Clinical Characteristics of Patients With Anti‐Signal Recognition Particle Antibody: A Cohort Study
Immunity, Inflammation and Disease · 2026
DOI: 10.1002/iid3.70297 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Immunity, Inflammation and Disease, 2026. Verfasst von Ameen Jubber und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Hospitals of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Signal Recognition Particle, Autoantibodies, Myositis. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anti‐signal recognition particle (anti‐SRP) antibodies are myositis‐specific autoantibodies associated with immune‐mediated necrotizing myopathy. This study was undertaken to better understand how patients with anti‐SRP antibodies have been managed at our tertiary centre and to assess the spectrum of clinical features and outcomes in routine clinical practice.
Methods
We conducted a retrospective evaluation of 25 patients with anti‐SRP antibodies identified via line‐blot immunoassay at a tertiary care centre (2019–2024). Demographic, clinical, serological, and imaging data were reviewed.
Results
The group of patients had a mean age of 60.1 years, with a female‐to‐male ratio of 10:15. Eight patients (32%) were diagnosed with myositis, primarily presenting with proximal muscle weakness. Interstitial lung disease was observed in 53% of the group of patients, and 50% of the subset of patients with myositis. Coexisting myositis‐specific autoantibodies were present in 32%, and 48% had positive antinuclear antibody titres (≥ 1:400). Cardiac involvement was reported in two myositis patients. Corticosteroids, often combined with mycophenolate mofetil or other immunosuppressants, formed the basis of treatment.
Conclusion
Anti‐SRP antibodies are associated with a heterogeneous clinical spectrum, with many patients lacking myositis features. There was a high prevalence of coexisting autoantibodies. Further studies are needed to elucidate the pathogenic role of anti‐SRP and optimise management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospitals of Leicester, Leicester, UK.
- University of Leicester, Leicester, UK.
ORCID-Profile: Kehinde Sunmboye
Zitieren
APA
Jubber, A., Durrani, M., Almayahi, A., & Sunmboye, K. (2026). Clinical Characteristics of Patients With Anti‐Signal Recognition Particle Antibody: A Cohort Study. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70297
Vancouver
Jubber A, Durrani M, Almayahi A, Sunmboye K. Clinical Characteristics of Patients With Anti‐Signal Recognition Particle Antibody: A Cohort Study. Immunity, Inflammation and Disease. 2026. doi:10.1002/iid3.70297
BibTeX
@article{Jubber2026,
author = {Jubber, Ameen and Durrani, Maumer and Almayahi, Abdullah and Sunmboye, Kehinde},
title = {Clinical Characteristics of Patients With Anti‐Signal Recognition Particle Antibody: A Cohort Study},
journal = {Immunity, Inflammation and Disease},
year = {2026},
doi = {10.1002/iid3.70297}
}
EUVIMED